Proof-of-concept study of the ghrelin mimetic ipamorelin for postoperative ileus (Phase 2, discontinued)
Independent researchers, using a different delivery mechanism and a different target tissue, arrived at the same conclusion: you can engineer cells to produce GLP-1 durably from a single treatment
Please note that some exclusions may apply
Da es sich um Peptide handelt, die strukturell dem Inkretin GLP-1 hneln, werden sie in der Regel parenteral appliziert (Ausnahme z.B
Tiny drops
For instance, exenatide, the first GLP-1-analogue developed, demonstrated to promote human monocyte differentiation into alternatively activated M2 macrophages, leading to an increase in anti-inflammatory cytokines such as IL-10 while significantly reducing pro-inflammatory cytokines, including IL-6, TNF- and IL-1 ( Furthermore, GLP-1 has been hypothesised to act as a mediator between innate and adaptive immune responses